0.00
price down icon100.00%   -9.02
after-market 시간 외 거래: 9.32 9.32 +
loading
전일 마감가:
$9.02
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
Value
$0.00
$0.00
1주일 범위
Value
$0.00
$9.41
52주 변동 폭
Value
$0.00
$16.27

Range Cancer Therapeutics Etf Stock (CNCR) Company Profile

Name
명칭
Range Cancer Therapeutics Etf
Name
전화
-
Name
주소
-
Name
직원
0
Name
트위터
@LoncarFunds
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
CNCR's Discussions on Twitter

CNCR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Exchange Traded Fund icon
CNCR
Range Cancer Therapeutics Etf
0.00 0 0 0 0 0.00
Exchange Traded Fund icon
VTI
Vanguard Total Stock Market Etf
291.36 417.53B 0 0 0 0.00
Exchange Traded Fund icon
SPY
Spdr S P 500 Etf Trust
592.71 372.57B 0 0 0 0.00
Exchange Traded Fund icon
IVV
Ishares Core S P 500 Etf
595.59 253.41B 0 0 0 0.00
Exchange Traded Fund icon
VB
Vanguard Small Cap Etf
227.86 160.59B 0 0 0 0.00
Exchange Traded Fund icon
QQQ
Invesco Qqq Trust Series 1
523.21 124.43B 0 0 0 0.00

Range Cancer Therapeutics Etf 주식(CNCR)의 최신 뉴스

pulisher
May 30, 2025

Summit stock down after cancer trial data (update) (NASDAQ:SMMT) - Seeking Alpha

May 30, 2025
pulisher
May 29, 2025

Friday's big stock stories: What’s likely to move the market in the next trading session - CNBC

May 29, 2025
pulisher
May 20, 2025

5 Small-cap Biotech ETFs to Watch - Investing News Network

May 20, 2025
pulisher
May 18, 2025

Trend Tracker for (CNCR) - news.stocktradersdaily.com

May 18, 2025
pulisher
May 14, 2025

CIBC Asset Management launches three new actively managed CIBC ETFs, expanding its cash management and fixed income ETF suite - The Globe and Mail

May 14, 2025
pulisher
May 10, 2025

Weekly ETF Industry Recap: U.S., Europe, and Canada HighlightsMay 5-10, 2025 - Trackinsight

May 10, 2025
pulisher
May 08, 2025

Exchange Traded Concepts to Close and Liquidate the Range Cancer Therapeutics ETF - The Joplin Globe

May 08, 2025
pulisher
May 08, 2025

Learn to Evaluate (CNCR) using the Charts - news.stocktradersdaily.com

May 08, 2025
pulisher
Apr 28, 2025

Mythic Therapeutics Presents Preclinical Data Demonstrating Potent Efficacy of MYTX-011 Across a Broad Range of Tumor Xenograft Models Harboring Clinically Relevant Mutations at the American Association for Cancer Research (AACR) Annual Meeting - Yahoo Finance

Apr 28, 2025
pulisher
Apr 23, 2025

Cathie Wood Bets on Nvidia, AMD Despite Chip Curbs and Dumps Microsoft Stock - The Globe and Mail

Apr 23, 2025
pulisher
Apr 22, 2025

Long Term Trading Analysis for (CNCR) - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 21, 2025

7 Best Pharmaceutical Stocks to Buy for Income - US News Money

Apr 21, 2025
pulisher
Apr 08, 2025

From Panic to Positioning: Top ETFs to Watch After Asia’s Tariff Shock - The Globe and Mail

Apr 08, 2025
pulisher
Apr 06, 2025

(CNCR) Investment Report - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 04, 2025

10 Best Health Care Stocks to Buy for 2025 - US News Money

Apr 04, 2025
pulisher
Apr 03, 2025

7 Top Gene-Editing Stocks to Buy | Investing | U.S. News - Money/ US News

Apr 03, 2025
pulisher
Mar 28, 2025

Best Stocks Under $20 Right Now - Benzinga

Mar 28, 2025
pulisher
Mar 27, 2025

Sellas Life Sciences Advances in Cancer Treatment Development - TipRanks

Mar 27, 2025
pulisher
Mar 25, 2025

ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025 - Nasdaq

Mar 25, 2025
pulisher
Mar 20, 2025

Akari Therapeutics Appoints Biotechnology Industry Leader, Abizer Gaslightwala, as President and Chief Executive Officer - Nasdaq

Mar 20, 2025
pulisher
Mar 19, 2025

QQQ ETF News, 3/19/2025 - The Globe and Mail

Mar 19, 2025
pulisher
Mar 16, 2025

(CNCR) Proactive Strategies - Stock Traders Daily

Mar 16, 2025
pulisher
Mar 15, 2025

Nasdaq Correction: Buy This Unstoppable ETF at a Discount - The Globe and Mail

Mar 15, 2025
pulisher
Mar 14, 2025

Buffer ETFs to Consider for Protecting Gains and Limiting Losses - The Globe and Mail

Mar 14, 2025
pulisher
Mar 14, 2025

S&P 500 Index Funds Yield Just 1.3%. Consider Buying These 2 Low-Cost Vanguard ETFs to Generate More Passive Income. - The Globe and Mail

Mar 14, 2025
pulisher
Mar 14, 2025

VOO ETF News, 3/14/2025 - The Globe and Mail

Mar 14, 2025
pulisher
Mar 12, 2025

VOO ETF News, 3/12/2025 - The Globe and Mail

Mar 12, 2025
pulisher
Mar 12, 2025

Is the Fidelity High Dividend ETF the Smartest Investment You Can Make Today? - The Globe and Mail

Mar 12, 2025
pulisher
Mar 11, 2025

Vanguard High Dividend Yield ETF vs Vanguard Dividend Appreciation ETF: Which Is Best for You? - The Globe and Mail

Mar 11, 2025
pulisher
Mar 11, 2025

These 2 Vanguard ETFs Are Crushing the S&P 500 in 2025. Should You Buy? - The Globe and Mail

Mar 11, 2025
pulisher
Mar 11, 2025

SCHD ETF News, 3/11/2025 - The Globe and Mail

Mar 11, 2025
pulisher
Mar 11, 2025

1 No-Brainer Artificial Intelligence (AI) ETF to Buy With $40 During the Nasdaq Sell-Off - The Globe and Mail

Mar 11, 2025
pulisher
Mar 08, 2025

Why You Can Do Better Than the SPDR S&P 500 ETF Trust - The Globe and Mail

Mar 08, 2025
pulisher
Mar 07, 2025

3 Top Cancer Biotechs to Keep An Eye On in 2025 - Yahoo Finance

Mar 07, 2025
pulisher
Mar 06, 2025

Best Biotech Stocks to Buy in 2025 - The Motley Fool

Mar 06, 2025
pulisher
Mar 05, 2025

(CNCR) Investment Analysis - news.stocktradersdaily.com

Mar 05, 2025
pulisher
Mar 03, 2025

7 Best-Performing Biotech ETFs for March 2025 - NerdWallet

Mar 03, 2025
pulisher
Feb 28, 2025

Top ETFs to Invest in Japan - The Globe and Mail

Feb 28, 2025
pulisher
Feb 26, 2025

N2OFF, Inc. Enters Agreement to Acquire MitoCareX Bio Ltd. to Expand Cancer Therapeutics Portfolio - Nasdaq

Feb 26, 2025
pulisher
Feb 25, 2025

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025 - Investing News Network

Feb 25, 2025
pulisher
Feb 24, 2025

CIBC Asset Management announces CIBC ETF cash distributions for February 2025 - The Globe and Mail

Feb 24, 2025
pulisher
Feb 23, 2025

(CNCR) Trading Signals - Stock Traders Daily

Feb 23, 2025
pulisher
Feb 20, 2025

The Unstoppable Momentum in Oncology M&A - Nasdaq

Feb 20, 2025
pulisher
Feb 18, 2025

2025 Outlook: Healthcare Technology & Innovation - ETF Trends

Feb 18, 2025
pulisher
Feb 14, 2025

This Warren Buffett Index Fund Could Turn $400 Per Month Into $868,200 - The Globe and Mail

Feb 14, 2025
pulisher
Feb 10, 2025

Psychedelic ETF PSIL Is 2025's Best-Performing ETF - etf.com

Feb 10, 2025
pulisher
Feb 07, 2025

TransCode Therapeutics (NASDAQ:RNAZ) Receives Buy Rating from HC Wainwright - Armenian Reporter

Feb 07, 2025
pulisher
Feb 01, 2025

When (CNCR) Moves Investors should Listen - Stock Traders Daily

Feb 01, 2025
pulisher
Jan 28, 2025

SELLAS Life Sciences Group, Inc. Secures $25 Million in Registered Direct Offering for Cancer Therapeutics Development - Nasdaq

Jan 28, 2025
pulisher
Jan 27, 2025

Reston Hospital Center adds inpatient unit to expand its range of oncology services - Yahoo Finance

Jan 27, 2025
pulisher
Jan 23, 2025

5 US Longevity and Anti-aging Stocks to Watch in 2025 - Investing News Network

Jan 23, 2025

Range Cancer Therapeutics Etf (CNCR) 재무 분석

Range Cancer Therapeutics Etf (CNCR)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
exchange_traded_fund VTV
$171.67
price up icon 0.16%
exchange_traded_fund VUG
$416.13
price up icon 0.72%
exchange_traded_fund IJH
$59.96
price down icon 0.13%
exchange_traded_fund EFA
$89.76
price up icon 1.07%
exchange_traded_fund IWF
$401.95
price up icon 0.63%
exchange_traded_fund QQQ
$523.21
price up icon 0.79%
자본화:     |  볼륨(24시간):